UNC Health Care

Tag: painful crisis

UNC Chapel

March 13, 2017

‘Conversations with Innovators:’ UNC hematologist on promising drug...

Kenneth Ataga, MD, director of the UNC Comprehensive Sickle Cell Program, was featured in a video by the American Society of Hematology in which he discussed the favorable results of a yearlong clinical trial studying crizanlizumab as a therapy to prevent and treat painful crisis events in patients with sickle cell disease.

Clinical Trials, Hematology, Vaccines

Read Article